Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Louzanne breaks own world record in Switzerland
2017-06-09

Description: Louzanne breaks own world record  Tags: Louzanne breaks own world record

Rufus Botha (left), coach of the athlete Louzanne Coetzee,
went overseas with Coetzee and her guide,
Khothatso Mokone, for a race for the first time.
Coetzee improved her T11 5 000 m world record with more
than 20 seconds in Switzerland.
Photo: Johan Roux

She fought against illness, had to get the green light from medical personnel shortly before her main race, and was very nervous. However, on 5 June 2017, the blind athlete Louzanne Coetzee managed to improve the T11 5 000 m world record with more than 20 seconds.

The Kovsie star’s time of 18:14.27 at the ParAthletics Grand Prix in Nottwil, Switzerland, was approximately 23 seconds faster than her previous world record (18:37.23). In addition, Coetzee, who works at the Institute for Reconciliation and Social Justice at the University of the Free State, also improved the South African T11 800 m record to 2:30.18 on 2 June 2017, and her 4:59.54 on 3 June 2017 in the T11 1 500 m was almost another national record.

Carried by UFS and other support
“One could never be ungrateful when running close to your personal best,” Coetzee said. “Fortunately, with God’s blessing, the support of everybody at home, support from the university, as well as my mom and them, it really was a very blessed and successful event.”

According to her coach, Rufus Botha, Coetzee was not feeling well before the event and had to get medical clearance before the 5 000 m. He told her not to run too hard, even though their goal was 18:20. “She ran an incredible final 600 m, which brought the time down to 18:14,” he said. “It was amazing to watch.”

Botha’s knowledge valuable abroad
He enjoyed going overseas with Coetzee and her guide, Khothatso Mokone, for the first time. “His (Botha’s) experience, knowledge, support, and coaching was extremely valuable,” Coetzee said. “It will definitely help me in future: how to approach things, and everything he shared with us.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept